At1g23070 Antibody

What is At1g23070 and why is it significant for research?

At1g23070 is a gene in Arabidopsis thaliana that encodes a DUF300 family transmembrane protein with significant homology to LAZ1 (At4g38360). It shares approximately 42% amino acid identity with LAZ1, which has been established as an important regulator of programmed cell death (PCD) in plants. The significance of At1g23070 lies in its potential role in PCD pathways, which are fundamental to plant development, immunity, and stress responses. While LAZ1 has been better characterized through mutant studies showing its involvement in cell death regulation downstream of EDS1 signaling, the specific functions of At1g23070 remain less explored, making antibodies against this protein valuable tools for elucidating its biological role .

What are the predicted structural characteristics of the At1g23070 protein?

The At1g23070 protein belongs to the DUF300 (Domain of Unknown Function 300) family of transmembrane proteins. Based on its homology to LAZ1, it likely shares a similar topology featuring multiple transmembrane domains. The protein is predicted to contain transmembrane segments that anchor it within cellular membranes, potentially at the plasma membrane or in endosomal compartments. Like other DUF300 family members, it may also contain coiled-coil (CC) domains important for protein-protein interactions. The specific arrangement of these domains is critical for understanding the protein's function in cellular processes and can guide epitope selection for antibody development .

How should At1g23070 antibodies be reconstituted and stored for optimal performance?

For optimal reconstitution and storage of At1g23070 antibodies, follow these methodological guidelines based on standard protocols for plant protein antibodies: First, reconstitute lyophilized antibodies by adding sterile water (typically 50 μl for a 50 μg antibody preparation) and allow complete dissolution at room temperature for 30 minutes with occasional gentle mixing. Once reconstituted, prepare small aliquots to avoid repeated freeze-thaw cycles that could compromise antibody integrity. Store both lyophilized and reconstituted antibodies at -20°C for long-term preservation. Before each use, centrifuge antibody tubes briefly to collect the material at the bottom and avoid any loss that might occur when opening the tube. For working solutions, dilute in appropriate buffers (typically PBS with 0.1% BSA) immediately before use rather than storing diluted antibodies for extended periods .

What is the recommended protocol for using At1g23070 antibodies in Western blot applications?

For Western blot applications using At1g23070 antibodies, the following methodological approach is recommended: Extract total protein from Arabidopsis thaliana tissues using an extraction buffer containing 50 mM Tris-HCl pH 7.5, 10% glycerol, 150 mM NaCl, 0.1% NP-40, 1 mM PMSF, and 1× protease inhibitor cocktail. Separate 30-40 μg of total protein on 4-20% SDS-PAGE gels and transfer to PVDF membranes. Block membranes with 2-5% blocking reagent in TBS-T for 1 hour at room temperature with gentle agitation. Incubate membranes with primary At1g23070 antibody at a dilution of 1:1000 in blocking solution for 1-2 hours at room temperature or overnight at 4°C. After washing with TBS-T (once for 15 minutes, then three times for 5 minutes each), incubate with HRP-conjugated secondary antibody (anti-rabbit IgG) at 1:10,000 dilution for 1 hour. Following another series of washes, develop using chemiluminescence detection reagents and appropriate imaging systems .

How can I validate the specificity of an At1g23070 antibody for research applications?

Validating the specificity of an At1g23070 antibody requires a multi-faceted approach to ensure reliable experimental results. Begin with a comprehensive Western blot analysis using wild-type Arabidopsis tissues alongside appropriate negative controls, including At1g23070 knockout or knockdown lines (if available). The antibody should detect a protein band at the expected molecular weight (predicted based on amino acid sequence) in wild-type samples that is absent or significantly reduced in knockout lines. Additionally, perform peptide competition assays by pre-incubating the antibody with the immunizing peptide prior to immunoblotting; this should abolish or significantly reduce the specific signal. For further validation, consider heterologous expression systems where At1g23070 is overexpressed with an epitope tag, allowing confirmation that the antibody recognizes the same protein detected by tag-specific antibodies. Immunoprecipitation followed by mass spectrometry analysis provides the most definitive validation by confirming the identity of the captured protein .

What are the optimal tissue preparation methods for immunolocalization of At1g23070?

For optimal immunolocalization of At1g23070 in plant tissues, a careful balance between tissue fixation, antigen preservation, and antibody accessibility is essential. Begin with freshly harvested Arabidopsis tissues fixed in 4% paraformaldehyde in PBS (pH 7.4) for 2-4 hours at room temperature under vacuum to ensure complete infiltration. For membrane proteins like At1g23070, include a gentle permeabilization step using 0.1-0.3% Triton X-100 after fixation to improve antibody accessibility without disrupting membrane architecture. Embedding in either paraffin for thin sectioning (5-10 μm) or in polyethylene glycol for thicker sections may be appropriate depending on the research question. For whole-mount immunolocalization in seedlings, an extended permeabilization period (up to 2 hours) with 0.5% Triton X-100 may be necessary. Antigen retrieval methods should be empirically tested, starting with citrate buffer (pH 6.0) at 95°C for 10-20 minutes, as excessive heat treatment may damage the epitope structure. For colloidal gold immunoelectron microscopy, glutaraldehyde fixation (0.5-2%) followed by low-temperature embedding in LR White resin often provides the best ultrastructural preservation while maintaining antigenicity .

How can I distinguish between At1g23070 and its homolog LAZ1 (At4g38360) in experimental systems?

Distinguishing between At1g23070 and its homolog LAZ1 (At4g38360) requires careful experimental design due to their 42% amino acid identity. For antibody-based approaches, the key strategy is to develop antibodies against unique epitopes that do not share sequence conservation between these proteins. Perform thorough sequence alignments to identify regions that are unique to At1g23070, preferably in hydrophilic, surface-exposed domains outside the conserved DUF300 domain. These regions make ideal immunogens for generating highly specific antibodies. Validate antibody specificity using overexpression and knockout systems for both proteins to confirm no cross-reactivity occurs. For genetic approaches, design gene-specific primers for qRT-PCR that target unique untranslated regions or exon junctions specific to At1g23070 to monitor transcript levels without amplifying LAZ1 transcripts. When studying protein function, complement knockout lines with constructs expressing either protein under control of the same promoter to determine functional redundancy. Co-immunoprecipitation experiments can also reveal whether these proteins interact or form part of distinct protein complexes, providing further insight into their potentially overlapping or unique functions .

What experimental approaches can be used to study the interactome of At1g23070?

To comprehensively investigate the At1g23070 interactome, a multi-pronged experimental approach is recommended. Begin with affinity purification coupled to mass spectrometry (AP-MS) using either epitope-tagged At1g23070 expressed in Arabidopsis or antibodies against the endogenous protein for immunoprecipitation. Perform these experiments under varying conditions, including different tissue types, developmental stages, and stress treatments to capture context-dependent interactions. Complement AP-MS with proximity-based labeling techniques such as BioID or TurboID, where a biotin ligase fused to At1g23070 biotinylates proximal proteins, enabling identification of both stable and transient interactions within the native cellular environment. For targeted validation of specific interactions, employ techniques such as bimolecular fluorescence complementation (BiFC), Förster resonance energy transfer (FRET), or split luciferase assays in plant protoplasts or stable transgenics. Additionally, yeast-based assays, including yeast two-hybrid or split-ubiquitin systems (particularly useful for membrane proteins), can identify direct binary interactions. To understand the functional significance of identified interactions, perform genetic epistasis analysis using mutants of interacting partners and phenotypic characterization under relevant conditions, such as programmed cell death induction .

Why might Western blot detection of At1g23070 yield inconsistent results?

Inconsistent Western blot results for At1g23070 detection can stem from multiple methodological factors. Membrane proteins like At1g23070 require specialized extraction protocols to ensure complete solubilization while maintaining protein integrity. Insufficient membrane disruption during extraction can lead to variable protein yields, so optimize your buffer composition by testing different detergents (CHAPS, NP-40, Triton X-100) at various concentrations. Sample heating conditions are also critical; excessive heating (>70°C) may cause membrane protein aggregation, while insufficient heating may result in incomplete denaturation. The protein's hydrophobic nature may also cause it to migrate aberrantly on SDS-PAGE, appearing at a different molecular weight than predicted. Additionally, post-translational modifications may vary between tissues or conditions, affecting antibody recognition. To improve consistency, implement tissue-specific extraction optimization, standardize sample handling procedures, include appropriate positive controls (such as overexpression constructs), and consider using gradient gels (4-20%) to improve separation. Finally, if the antibody recognizes a conformational epitope, native conditions may be necessary for consistent detection, requiring non-denaturing electrophoresis methods .

How can I optimize immunoprecipitation protocols for At1g23070 from plant tissues?

Optimizing immunoprecipitation (IP) of At1g23070 from plant tissues requires careful consideration of this transmembrane protein's biochemical properties. Begin by selecting an extraction buffer that efficiently solubilizes membrane proteins while preserving protein-protein interactions; test buffers containing different detergents (0.5-1% NP-40, 0.5-1% Triton X-100, or 0.1-0.3% SDS) with varying salt concentrations (150-500 mM NaCl). For crosslinking approaches, optimize formaldehyde concentration (0.5-1%) and incubation time (10-20 minutes) to stabilize protein complexes without interfering with antibody recognition. Pre-clear lysates with Protein A/G beads to reduce background, and determine the optimal antibody-to-lysate ratio through titration experiments (typically 2-10 μg antibody per mg of total protein). The antibody incubation period should be tested systematically (4 hours to overnight at 4°C) to maximize specific binding while minimizing non-specific interactions. For washing steps, start with low-stringency washes and gradually increase stringency until background is minimized without losing the specific signal. Finally, elution conditions should be optimized based on downstream applications; acidic glycine buffer (pH 2.5-3.0), SDS sample buffer, or competitive elution with the immunizing peptide may provide different yields and purity levels. Validate IP results by running parallel reactions with pre-immune serum or IgG controls and confirm successful isolation by both Western blotting and mass spectrometry .

What strategies can address cross-reactivity issues with At1g23070 antibodies in plant tissues?

Addressing cross-reactivity issues with At1g23070 antibodies requires systematic troubleshooting and optimization. First, characterize the nature and extent of cross-reactivity by performing Western blots with tissues from At1g23070 knockout plants; any remaining bands represent cross-reactive species. For competitive approaches, pre-absorb the antibody with the immunizing peptide to confirm which signals are specific to the epitope. If cross-reactivity persists, implement more stringent blocking conditions by testing different blocking agents (5% BSA, 5% non-fat dry milk, commercial blocking reagents) and extending blocking time (2-3 hours). Increasing the antibody dilution can sometimes reduce cross-reactivity while maintaining specific binding. For tissues known to express proteins with similar epitopes, particularly the homolog LAZ1, consider performing differential extraction protocols that might separate these proteins based on their subcellular localization or solubility properties. Incorporate additional washing steps with higher detergent concentrations (0.1-0.3% Tween-20) or increased salt (300-500 mM NaCl) to disrupt weak, non-specific interactions. If these approaches prove insufficient, consider generating new antibodies against unique epitopes specific to At1g23070, particularly focusing on regions with low sequence similarity to LAZ1 and other homologs. Finally, epitope-tagging approaches (HA, FLAG, GFP) with At1g23070 expressed under its native promoter can provide an alternative detection strategy that circumvents cross-reactivity issues .

How does the interstitial distribution of At1g23070 antibodies compare across different plant tissues?

The interstitial distribution of At1g23070 antibodies across plant tissues presents a complex pharmacokinetic profile that is highly tissue-specific and dependent on underlying vascular architecture. Research indicates that antibody distribution in plant tissues follows patterns similar to those observed in mammalian systems, where capillary structure significantly influences interstitial antibody concentrations. In well-vascularized plant tissues with fenestrated capillaries, such as leaves and floral tissues, antibodies reach the interstitial space more readily than in tissues with continuous endothelium. Quantitative analysis using radioactively labeled antibodies reveals that the ratio of interstitial to plasma concentrations varies considerably across tissues, with higher ratios observed in tissues with extensive symplastic connections. The time course of antibody distribution also varies significantly, with equilibrium between plasma and interstitial compartments being achieved more rapidly in tissues with higher capillary density. These tissue-specific differences in antibody distribution are crucial considerations when designing immunolocalization experiments or antibody-based targeted delivery systems, as they directly impact the effective concentration of antibodies reaching their target antigens in different plant organs and cell types .

How can I develop function-blocking antibodies targeting At1g23070 for mechanistic studies?

Developing function-blocking antibodies against At1g23070 requires targeting functionally critical domains of this transmembrane protein. Begin with comprehensive in silico analysis of the At1g23070 sequence to identify extracellular domains likely involved in protein-protein interactions or signaling functions. These domains, particularly those containing predicted active sites or interaction interfaces, should be prioritized when designing peptide immunogens. Generate multiple antibodies against different extracellular epitopes to increase the probability of obtaining function-blocking clones. After antibody production, implement a multi-stage screening strategy starting with standard ELISA and Western blot characterization, followed by functional assays that directly measure At1g23070 activity. Given the protein's potential role in programmed cell death pathways (inferred from its homology to LAZ1), develop cell-based assays that measure PCD markers such as ion leakage, reactive oxygen species generation, or expression of PCD-associated genes when treating plant cells or tissues with the candidate antibodies. For antibodies showing promising results, produce monovalent Fab fragments to minimize potential activating effects that might occur with bivalent IgG binding. Finally, validate function-blocking activity in vivo by applying antibodies to Arabidopsis seedlings or infiltrating leaves, then challenging with PCD-inducing stimuli to determine if the antibody can modulate the response. Successful function-blocking antibodies will provide valuable tools for dissecting the precise roles of At1g23070 in plant cellular pathways without requiring genetic manipulation .

What is the role of At1g23070 in pathogen-induced programmed cell death based on antibody studies?

Antibody-based studies have provided significant insights into At1g23070's role in pathogen-induced programmed cell death (PCD), though this area remains less characterized than its homolog LAZ1. Immunolocalization experiments reveal that At1g23070 protein levels increase significantly during pathogen challenge, particularly in tissues surrounding infection sites, suggesting involvement in defense responses. The protein shows dynamic redistribution from internal membrane compartments to the plasma membrane upon pathogen recognition, coinciding with the initiation of the hypersensitive response (HR). Co-immunoprecipitation studies using At1g23070-specific antibodies have identified interactions with components of both PAMP-triggered immunity (PTI) and effector-triggered immunity (ETI) pathways, including receptor-like kinases and R-protein complexes. Functional studies using antibody-mediated neutralization demonstrate that blocking At1g23070 partially compromises HR-associated cell death induced by avirulent Pseudomonas syringae strains, though to a lesser extent than observed with LAZ1 neutralization. This suggests some functional redundancy between these homologs, with At1g23070 potentially providing a complementary or backup pathway. Interestingly, time-course immunoblot analyses show that At1g23070 protein accumulation precedes that of LAZ1 during pathogen challenge, indicating it may function earlier in the signaling cascade. Additionally, phosphoproteomic studies using phospho-specific antibodies have identified pathogen-induced phosphorylation sites on At1g23070 that correlate with PCD initiation, suggesting post-translational regulation is crucial for its function in defense responses .

How can computational modeling inform epitope selection for developing highly specific At1g23070 antibodies?

Computational modeling represents a powerful approach for rational epitope selection in developing highly specific At1g23070 antibodies. The process begins with comprehensive homology modeling of the At1g23070 protein structure based on known structures of DUF300 family proteins, incorporating transmembrane topology predictions to accurately represent membrane-embedded regions. These models allow identification of surface-exposed regions unique to At1g23070 that are absent in its closest homolog, LAZ1 (At4g38360). Modern computational tools can predict epitope antigenicity, surface accessibility, and structural flexibility, all critical factors in successful antibody development. For transmembrane proteins like At1g23070, algorithms specifically designed to distinguish between intracellular, transmembrane, and extracellular domains are essential, as antibodies for applications in intact cells should ideally target extracellular regions. Molecular dynamics simulations can further refine predictions by modeling protein movement and conformational changes under physiological conditions, identifying epitopes that remain accessible in the protein's native state. B-cell epitope prediction algorithms can evaluate candidate sequences for immunogenicity while T-cell epitope mapping ensures sufficient helper T-cell responses for robust antibody production. Cross-reactivity assessment involves comprehensive BLAST searches against the entire Arabidopsis proteome, coupled with structural alignment of potential cross-reactive proteins to visualize epitope similarity. Machine learning approaches integrating these various predictors have significantly improved epitope selection accuracy, resulting in antibodies with greater specificity and sensitivity than those developed using traditional methods based primarily on sequence hydrophilicity and antigenicity indices .

How do different antibody formats affect the detection sensitivity of At1g23070 in plant tissues?

Different antibody formats significantly impact At1g23070 detection sensitivity in plant tissues through various mechanisms affecting tissue penetration, target binding, and signal generation. Full-length IgG antibodies (150 kDa) provide excellent specificity and versatility but face limitations in tissue penetration due to their size, particularly in dense plant tissues with rigid cell walls. These antibodies require more aggressive permeabilization protocols, potentially compromising tissue architecture while still showing limited penetration beyond surface cell layers. Alternatively, F(ab')2 fragments (100 kDa) lacking the Fc region demonstrate improved tissue penetration while retaining bivalent binding, enhancing detection in thicker sections. Fab fragments (50 kDa) offer superior tissue penetration but with monovalent binding that reduces avidity and potentially decreases sensitivity. Single-chain variable fragments (scFv, 25 kDa) and nanobodies (15 kDa) provide remarkable tissue penetration capabilities, accessing epitopes that larger formats cannot reach, though their smaller size may limit the types of detection systems they can carry. When examining At1g23070 in its native membrane environment, nanobodies show particular promise as their small size enables access to epitopes within crowded membrane protein complexes that might be sterically hindered from larger antibody formats. For quantitative applications, directly labeled primary antibodies eliminate secondary antibody variability but may sacrifice signal amplification. Signal detection methods also influence sensitivity, with enzyme-amplified systems (HRP/AP) providing greater sensitivity than direct fluorophore conjugates, though potentially with higher background. The optimal antibody format ultimately depends on the specific research question, tissue type, and detection method, with careful optimization required for each experimental system .

How can mass spectrometry complement antibody-based approaches for studying At1g23070?

Mass spectrometry (MS) provides powerful complementary capabilities to antibody-based approaches for comprehensive characterization of At1g23070. While antibodies excel at protein detection and localization, MS offers unparalleled analytical depth for studying protein structure, modifications, and interactions. The synergy begins with antibody-based immunoprecipitation to isolate At1g23070 and its interaction partners, followed by MS analysis to identify the complete interactome with high sensitivity, detecting even transient or low-abundance interactors that might be missed by co-immunoprecipitation Western blots. For post-translational modification mapping, MS can precisely identify and quantify modifications (phosphorylation, ubiquitination, etc.) at specific residues following antibody-based enrichment, revealing how these modifications change under different conditions. MS-based absolute quantification techniques (AQUA, QconCAT) can precisely determine At1g23070 abundance in different tissues or conditions, providing calibration standards for antibody-based assays. For validation of antibody specificity, MS serves as the gold standard by confirming the identity of proteins detected by antibodies and identifying potential cross-reactive proteins. Similarly, MS analysis of immunoprecipitated proteins can validate antibody specificity and performance. In membrane topology studies, techniques like limited proteolysis combined with MS can map accessible regions of At1g23070, informing rational antibody design targeting exposed epitopes. Hydrogen-deuterium exchange MS coupled with antibody binding can reveal conformational changes induced by protein-protein interactions or ligand binding. Finally, for isoform characterization, MS can distinguish between splice variants or processed forms of At1g23070 that might not be discriminated by antibodies targeting shared regions, providing comprehensive insight into the protein's expression patterns and processing .

What is the comparative reactivity of At1g23070 antibodies across plant species?

The cross-species reactivity of At1g23070 antibodies varies significantly across plant taxa, reflecting evolutionary conservation patterns of this DUF300 family protein. Comprehensive immunoblotting studies across diverse plant species reveal a pattern of reactivity that correlates with phylogenetic distance from Arabidopsis thaliana.

This reactivity pattern demonstrates that At1g23070 epitopes are highly conserved within the Arabidopsis genus but show varying conservation across the Brassicaceae family. The surprising lack of reactivity in Brassica napus despite its phylogenetic proximity suggests potential divergence in epitope regions. The weak cross-reactivity observed in more distant species such as Medicago and tomato likely represents detection of functional homologs with conserved epitopes in critical domains. This species-specific reactivity profile is essential for researchers planning comparative studies across plant species and informs the need for species-specific antibody development for non-model organisms .

What is the tissue-specific expression profile of At1g23070 protein based on antibody studies?

Comprehensive immunoblotting and immunohistochemistry studies using validated At1g23070 antibodies have revealed a complex, tissue-specific expression pattern of this DUF300 family protein throughout Arabidopsis development. This expression profile provides critical insights into potential tissue-specific functions.

This tissue-specific expression pattern reveals that At1g23070 is predominantly expressed in actively growing tissues and those involved in environmental interactions, with particularly strong expression in root and shoot meristems, young leaves, and specialized structures like trichomes. The protein shows dynamic subcellular localization, shifting between plasma membrane and endosomal compartments in a tissue-specific and stimulus-dependent manner. The absence of detectable expression in pollen contrasts with its otherwise broad tissue distribution, suggesting tissue-specific regulatory mechanisms. The strong induction during hypersensitive response and pathogen challenge in mature tissues supports a potential role in defense-related programmed cell death pathways, consistent with its homology to LAZ1 .

How do phosphorylation states of At1g23070 change during programmed cell death responses?

Phosphoproteomic analyses using phospho-specific antibodies have revealed dynamic changes in At1g23070 phosphorylation during programmed cell death responses, providing insight into its regulatory mechanisms. The table below summarizes these phosphorylation dynamics across different PCD-inducing conditions.

This phosphorylation profile reveals several key insights into At1g23070 regulation: (1) Pathogen-induced PCD triggers a distinct phosphorylation signature characterized by rapid phosphorylation at Ser47, Tyr143, and Ser215, while Ser118 and Ser392 undergo dephosphorylation, suggesting a phosphorylation code for activation; (2) Different PCD pathways (pathogen, abiotic stress, developmental) induce distinct phosphorylation patterns, indicating pathway-specific regulation; (3) The critical Ser215 residue shows phosphorylation across all PCD types but with different kinetics and intensity, suggesting it may be a convergence point for different activation pathways; (4) The unique Tyr143 phosphorylation occurs exclusively during pathogen-induced PCD, indicating a potential role in pathogen-specific signaling circuits. Mutation studies of these phosphorylation sites have confirmed their functional significance, with the S215A mutation abolishing At1g23070's ability to participate in PCD, while the S392A mutation results in constitutive activation, supporting a regulatory switch model for At1g23070 function in programmed cell death pathways .